These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 32037896)

  • 1. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
    Rathod VR; Shah DA; Dave RH
    Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen.
    Almeida H; Lobão P; Frigerio C; Fonseca J; Silva R; Sousa Lobo JM; Amaral MH
    Pharm Dev Technol; 2017 May; 22(3):336-349. PubMed ID: 28240141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
    Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques.
    Beg S; Saini S; Bandopadhyay S; Katare OP; Singh B
    Drug Dev Ind Pharm; 2018 Mar; 44(3):407-420. PubMed ID: 29048242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells.
    Costa CP; Cunha S; Moreira JN; Silva R; Gil-Martins E; Silva V; Azevedo L; Peixoto AF; Sousa Lobo JM; Silva AC
    Int J Pharm; 2021 Sep; 607():120933. PubMed ID: 34324988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
    Soni K; Rizwanullah M; Kohli K
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
    Abd-Elhakeem E; El-Nabarawi M; Shamma R
    Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain.
    Salunkhe SS; Bhatia NM; Bhatia MS
    Drug Deliv; 2016 May; 23(4):1306-16. PubMed ID: 25080227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.
    Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S
    Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Thermoresponsive Eyedrop Formulation Containing Ibuprofen Loaded-Nanostructured Lipid Carriers (NLC): Development, Characterization and Biocompatibility Studies.
    Almeida H; Lobão P; Frigerio C; Fonseca J; Silva R; Palmeira-de-Oliveira A; Lobo JM; Amaral MH
    Curr Drug Deliv; 2016; 13(6):953-70. PubMed ID: 26502890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers.
    Yang CR; Zhao XL; Hu HY; Li KX; Sun X; Li L; Chen DW
    Chem Pharm Bull (Tokyo); 2010 May; 58(5):656-61. PubMed ID: 20460792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
    Zafar A
    J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters.
    Cunha S; Costa CP; Loureiro JA; Alves J; Peixoto AF; Forbes B; Sousa Lobo JM; Silva AC
    Pharmaceutics; 2020 Jun; 12(7):. PubMed ID: 32605177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate Optimization of Rizatriptan Benzoate-Loaded Solid Lipid Nanoparticles for Brain Targeting and Migraine Management.
    Girotra P; Singh SK
    AAPS PharmSciTech; 2017 Feb; 18(2):517-528. PubMed ID: 27126007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design.
    Kim MH; Kim KT; Sohn SY; Lee JY; Lee CH; Yang H; Lee BK; Lee KW; Kim DD
    Int J Nanomedicine; 2019; 14():8509-8520. PubMed ID: 31749618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery.
    Varela-Fernández R; García-Otero X; Díaz-Tomé V; Regueiro U; López-López M; González-Barcia M; Isabel Lema M; Javier Otero-Espinar F
    Eur J Pharm Biopharm; 2022 Mar; 172():144-156. PubMed ID: 35183717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Nanostructured Lipid Carrier for Brain Delivery of Artemisinin: Design, Preparation, Characterization, Optimization and Cell Toxicity.
    Emami J; Yousefian H; Sadeghi H
    J Pharm Pharm Sci; 2018; 21(1s):225s-241s. PubMed ID: 30266137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation optimization, in vitro and in vivo evaluation of agomelatine-loaded nanostructured lipid carriers for augmented antidepressant effects.
    Gul M; Shah FA; Sahar NU; Malik I; Din FU; Khan SA; Aman W; Choi HI; Lim CW; Noh HY; Noh JS; Zeb A; Kim JK
    Colloids Surf B Biointerfaces; 2022 Aug; 216():112537. PubMed ID: 35561634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.